Seventy-five dogs with cytopathologically or histopathologically confirmed lymphoma received L-asparaginase, vincristine, cyclophosphamide, prednisone, and doxorubicin (COPLA) induction followed by chlorambucil, vincristine, and prednisone (LVP) maintenance between January 1994 and June 1997. Toxicity was evaluated using the National Cancer Institute (NCI) toxicity criteria. Age, weight, sex, and response were evaluated for prognostic significance against first remission duration. A complete response (CR) was obtained in 61 (80%) dogs, a partial response (PR) was obtained in nine (12%) dogs, and no response (NR) was obtained in five (8%) dogs. The median first remission duration was 25 weeks, with 17% and 5% of the dogs in remission at one and two years, respectively. Observed toxicity was low, with 84% of dogs given an NCI score of 1 or 2. Median survival time for dogs achieving CR was 36 weeks versus four weeks for those achieving PR or NR.
Skip Nav Destination
Article navigation
September/October 2000
Research Article|
September 01 2000
Treatment of canine lymphoma with COPLA/LVP
J Am Anim Hosp Assoc (2000) 36 (5): 395–403.
Citation
KL Boyce, BE Kitchell; Treatment of canine lymphoma with COPLA/LVP. J Am Anim Hosp Assoc 1 September 2000; 36 (5): 395–403. doi: https://doi.org/10.5326/15473317-36-5-395
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Evaluation of Intrathecal Injection of Modified Live Newcastle Disease Virus Vaccine in Dogs with Canine Distemper Encephalitis
Kenneth R. Harkin, DVM, DACVIM, Anushka George Karote, MS
Assessment of Adrenal Computed Tomography Characteristics in Cats with Nonadrenal Disease
Stefanie Gaisbauer, DVM, Florian Karl Zeugswetter, Priv. Doz., DVM, Alexander Tichy, Mag. phil., Dr. rer. nat., Conor Rowan, MVB, DVMS, DECVDI, MRCVS, Eberhard Ludewig, DMV habil., DECVDI
Prolonged Survival Following Treatment of Histiocytic Sarcoma of the Canine Urinary Bladder
Steve Patten, DVM, MSc, DACVIM (Oncology), Shawn MacKenzie, DVM, DVSc, DACVR
Anicteric Gallbladder Rupture with Elevated Bile Acids in Abdominal Effusion in a Dog with Cholecystitis
Mireia Pascual, DVM, Emilie Fauchon, DECVDI, Paola Monti, DACVP, Ferran Valls, DECVIM
Cholesterol Granuloma of the Cranial Mediastinum in a Dog
Anastacia Marie Davis, DVM, MS, DACVS, Kevin Lahmers, DVM, PhD, DACVP, Brie Trusiano, DVM, Kurt Zimmerman, DVM, PhD, DACVP, Jake Romeiser, DVM, Joanne Tuohy, DVM, PhD